Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01857440 · ClinicalTrials.gov registry record
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 32
- Enrollment target
NCT01857440: Completed study, sponsored by Ohio State University.
NCT01857440 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01857440 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This study is designed to investigate whether the pupil response to slowly flashing colored lights is significantly altered in patients with glaucoma, as compared to a control group of subjects without glaucoma.
Primary Outcome
Using fourier analysis, the pupil fluctuation evoked by blue and red flickering lights will be measured in glaucoma patients and compared to matched controls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-12 |
What the finished NCT01857440 record still lists
NCT01857440 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01857440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01857440 about?
NCT01857440 is a clinical study titled "The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study". This study is designed to investigate whether the pupil response to slowly flashing colored lights is significantly altered in patients with glaucoma, as compared to a control group of subjects without glaucoma.
What is the current status of trial NCT01857440?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2013-05. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01857440?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia